DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Which oncology KOLs should we prioritize for a variety of launch planning use cases?

 

Challenge

Which oncology KOLs should we prioritize for a variety of launch planning use cases ?

 

Download

 

The oncology team at a large pharmaceutical company was gearing up for multiple prostate cancer drug launches over the next 5 years. They wanted to establish their thought leadership and reputation in the market through a robust KOL strategy, that included KOLs for both traditional and emerging use cases like digital.

Finding the right influence for this purpose was different than their normal projects because:

  • They needed a lot of KOLs to work with, given that they have multiple drugs launching and thought leadership is a core strategy
  • The oncology KOL landscape is one of the most dynamic and varied in healthcare, with online influencers playing a bigger role than in other spaces

They needed a new analytics approach to build a robust directory of KOLs for multiple use cases:

  • Advisory boards (regional and national)
  • Speaker programs
  • Digital / social influencers
  • Future market shapers

 

Solution

Best fit KOLs were identified, scored and categorized via clinical, social, and academic influence analysis

The launch planning team partnered with DRG to build a custom grouping and scoring model to match KOLs to their multiple use cases.

DRG built a team of data scientists, oncology experts, market consultants, and digital specialists to create a robust scoring criteria based on a variety of data sources, including DRG claims data, publications, social influence and peer-to-peer recommendation.

 

After data extraction, priority HCPs were identified using a model to weight the relative importance of each metric for each KOL application. Additionally, key KOLs were profiled individually.

 

 

Through this integrated analysis and scoring model, we were able to help the client identify the best fit physicians for each unique use case, and their level of importance now, and potentially in the future.

 

 

Results

DRG armed the client with:

  • KOLs matched to their key use cases
  • National and regional KOLs to consider for advisory boards
  • KOL strategy recommendations for launch planning
  • Tableau database and web-based
  • Navigator reporting tool for network visualization

The client commented that many of the influential KOLs identified through the multi-data source analysis were unknown to them, and they could not have found them through traditional KOL analysis alone.

 

DRG Differentiators

  • World class data science and epidemiology data teams working in tandem to size the toughest populations
  • Consulting partners and therapeutic experts from the project outset, with deep market knowledge, ideas and fast answers – minimizing the time needed to “get up to speed”

 

Need help sizing your markets?

When you are faced with tough business questions, DRG analytics specialists are here to help you define the best path forward.

Visit: decisionresourcesgroup.com/analytics

Contact: questions@teamdrg.com

Read our latest executive briefing: Advanced Targeting: Activating Networks of Influence